Asi, Asmiya .
HRN: 26-57-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2025
CEFUROXIME 500MG (TAB)
01/23/2025
01/29/2025
PO
500mg
BID
PROM X 57hrs; RMLE And Repair
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes